跳至主要内容
临床试验/NCT01257126
NCT01257126撤回4 期

Efficacy of Diclofenac Potassium Versus Nimesulide in the Treatment of Fever and Pain in Children Aged 3 to 7 Years With Community Acquired, Non-complicated, Upper Respiratory Tract Infection

Novartis Pharmaceuticals0 个研究点开始时间: 2011年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
撤回
主要终点
Reduction of fever as measured by axillary temperature

研究概览

简要总结

This is a local, phase IV, open-label, randomized, head to head study of children aged 3 to 7 years. The objective of the study is to compare the efficacy of a single dose of both diclofenac potassium and nimesulide in the reduction of fever and pain secondary to upper respiratory tract infection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Years 至 7 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children who present community acquired, non-complicated, upper respiratory tract infection: rhino-sinusitis, pharyngitis, tonsillitis, ear infection or the combination of these.
  • Child must present axillary temperature ≥ 37.5°C.

排除标准

  • Prior history of allergic reaction to the components of the study medication.
  • Use of any NSAID or pharmacologic agent in the 24 hours prior to visit
  • Subjects who, in the opinion of the investigator, have developed, or are at risk of developing, a complicated infection and are not suitable subjects for the purposes of the study.
  • Other protocol-defined inclusion/exclusion criteria may apply

研究组 & 干预措施

diclofenac potassium

Experimental

干预措施: diclofenac potassium (Drug)

nimesulide

Active Comparator

干预措施: nimesulide (Drug)

结局指标

主要结局

Reduction of fever as measured by axillary temperature

时间窗: 120 minutes

次要结局

  • Reduction of pain as measured by visual analog scale(120 minutes)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验